CERIELLO, Antonio

CERIELLO, Antonio  

DIP. PATOLOGIA E MEDICINA SPERIMENTALE E CLINICA - DIPS (attivo dal 01/01/1900 al 22/09/2011)  

Mostra records
Risultati 1 - 20 di 266 (tempo di esecuzione: 0.051 secondi).
Titolo Data di pubblicazione Autore(i) File
'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting. 1-gen-2010 Ceriello, Antonio; Ihnat, M. A.
A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization. 1-gen-2007 Kamat, Cd; Thorpe, Je; Shenoy, Ss; Ceriello, Antonio; Green, De; Warnke, La; Ihnat, M. A.
A preliminary note on inhibiting effect of alpha-tocopherol (vit. E) on protein glycation. 1-gen-1988 Ceriello, Antonio; Giugliano, D; Quatraro, A; Dello Russo, P; Torella, R.
Acetylsalicylic acid and lysine inhibit protein glycosylation in vitro. A preliminary report 1-gen-1985 Ceriello, Antonio; Dello Russo, P; Curcio, Francesco; Giugliano, D; D'Onofrio, F.
Acute hyperglycaemia and oxidative stress generation. 1-gen-1997 Ceriello, Antonio
Acute hyperglycaemia: a 'new' risk factor during myocardial infarction 1-gen-2005 Ceriello, Antonio
Acute hyperglycemia induces an oxidative stress in healthy subjects. 1-gen-2001 Marfella, R; Quagliaro, L; Nappo, F; Ceriello, Antonio; Giugliano, D.
Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat 1-gen-2002 Ceriello, Antonio; Quagliaro, L; D'Amico, M; DI FILIPPO, C; Marfella, R; Nappo, F; Berrino, L; Rossi, F; Giugliano, D.
Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial. 1-gen-2008 Esposito, K; Ciotola, M; Maiorino, Mi; Gualdiero, R; Schisano, B; Ceriello, Antonio; Beneduce, F; Feola, G; Giugliano, D.
Administration of a new diabetes-specific enteral formula results in an improved 24h glucose profile in type 2 diabetic patients. 1-gen-2009 Ceriello, Antonio; Lansink, M; Rouws, Ch; van Laere, Km; Frost, G. S.
Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. 1-gen-2007 Lapolla, A; Piarulli, F; Sartore, G; Ceriello, Antonio; Ragazzi, E; Reitano, R; Baccarin, L; Laverda, B; Fedele, D.
Analysis of diabetic family connection in subjects with insulin-dependent diabetes mellitus (IDDM). 1-gen-1990 Quatraro, A; Consoli, G; Magno, M; Caretta, F; Ceriello, Antonio; Giugliano, D.
Angiotensin-receptor blockers, type 2 diabetes, and renoprotection. 1-gen-2002 Ceriello, Antonio; Motz, E.
Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. 1-gen-1991 Ceriello, Antonio; Giugliano, D; Quatraro, A; Lefebvre, P. J.
Antioxidant anti-inflammatory treatment in type 2 diabetes. 1-gen-2009 Ceriello, Antonio; Testa, R.
Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. 1-gen-1998 Ceriello, Antonio; Bortolotti, N; Crescentini, A; Motz, E; Lizzio, S; Russo, A; Ezsol, Z; Tonutti, L; Taboga, C.
Antioxidant therapy in diabetic complications: what is new? 1-gen-2004 Da Ros, R; Assaloni, R; Ceriello, Antonio
Antithrombin III and glycosylated hemoglobin in diabetic subjects 1-gen-1982 Tirelli, A; Misso, L; Varano, R; Coppola, L; Ceriello, Antonio; Capobianco, G.
Are there specific treatments for the metabolic syndrome? 1-gen-2008 Giugliano, D; Ceriello, Antonio; Esposito, K.
Aspirin and non-enzymatic glycation. 1-gen-1987 Ceriello, Antonio; Giugliano, D; Quatraro, A; Stante, A.